QT
PHAT icon

Quantbot Technologies’s Phathom Pharmaceuticals PHAT Stock Holding History

Quantbot Technologies’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-535
Closed -$8.88K – 2060
2025
Q4 		$8.88K Sell
535
-9,262
-95% -$132K ﹤0.01% 1603
2025
Q3 		$115K Buy
+9,797
New +$101K ﹤0.01% 1418
2023
Q1 		– Sell
-2,927
Closed -$32.8K – 1945
2022
Q4 		$32.8K Sell
2,927
-400
-12% -$4.12K ﹤0.01% 1373
2022
Q3 		$36K Sell
3,327
-2,200
-40% -$21K ﹤0.01% 1296
2022
Q2 		$46K Buy
5,527
+2,927
+113% +$30.1K ﹤0.01% 1319
2022
Q1 		$35K Sell
2,600
-200
-7% -$3.23K ﹤0.01% 1268
2021
Q4 		$55K Buy
2,800
+1,800
+180% +$42.4K ﹤0.01% 1002
2021
Q3 		$32K Buy
+1,000
New +$33.2K ﹤0.01% 1186

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Quantbot Technologies's PHAT Position: Q1 2026 in Review

Quantbot Technologies sold out of Phathom Pharmaceuticals (PHAT) in Q1 2026, closing a stake of 535 shares — an estimated $8.88K sold.

Quantbot Technologies first reported a position in PHAT in Q3 2021 and held it in 8 quarters. The position peaked at $115K in Q3 2025. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Quantbot Technologies reported no remaining Phathom Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 535 Phathom Pharmaceuticals shares in Q1 2026, an estimated $8.88K.
  • Quantbot Technologies first reported a position in Phathom Pharmaceuticals in Q3 2021 and held it in 8 quarters.
  • Quantbot Technologies's Phathom Pharmaceuticals position peaked at $115K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.